Stigma Podcast - Mental Health · 1 September 2020 · 47 min
Listen at the source: Stephen Hays ↗ · audio
Dr. Adam Gazzaley, founder of Akili Interactive joins us to talk about the intersection of molecular and experiential treatments for mental health conditions. Akili is the maker of the first ever video game to be approved by the FDA as a digital therapeutic treatment for a clinical condition. We talked about how Adam and his team figured out how to use video games in this manner, how they got approval to do so and the science that proves a video game can help improve cognitive function. We dig into the future interactions of molecular and experiential medicine and where his revolutionary treatments can take us as we learn to leverage technology to help us get better when it comes to mental health, not tear us down or make us worse which is often how people think of technology these days. In addition to his role as Founder of Akili Interactive, Adam is a co-founder of Jazz Venture Partners, and a professor of Neurology, Psychiatry and Physiology at UCSF. Dr. Adam Gazzaley obtained an M.D. and Ph.D. in Neuroscience at the Mount Sinai School of Medicine in New York, completed Neurology residency at the University of Pennsylvania, and postdoctoral training at University of California, Berkeley.
As published with the episode at Stigma Podcast - Mental Health ↗
No summary of this episode yet.